Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Di-p-toluoyl-d-tartaric Acid
2. Di-p-toluoyltartaric Acid
1. 32634-68-7
2. Di-p-toluoyl-d-tartaric Acid
3. (+)-di-1,4-toluoyl-d-tartaric Acid
4. (2s,3s)-2,3-bis((4-methylbenzoyl)oxy)succinic Acid
5. (+)-o,o'-di-p-toluoyl-d-tartaric Acid
6. Ditoluoyltartaric Acid, (+)-
7. (2s,3s)-2,3-bis[(4-methylbenzoyl)oxy]butanedioic Acid
8. (+)-dtta
9. Mfcd00008552
10. (+)-ditoluoyltartaric Acid
11. (2s,3s)-2,3-bis[(4-methylbenzoyl)oxy]succinic Acid
12. 4480ma5qip
13. (+)-di-p-toluoyl-d-tartaric Acid
14. Di-p-toluoyl-l-tartaric Acid
15. Nsc-97592
16. (+)-di-(p-toluoyl)-d-tartaric Acid
17. (+)-di-o-p-toluoyl-d-tartaric Acid
18. [s(r*,r*)]-2,3-bis[(4-methylbenzoyl)oxy]succinic Acid
19. (+)-di-p-toluoyl-d-(+)-tartaric Acid
20. Butanedioic Acid, 2,3-bis((4-methylbenzoyl)oxy)-, (2s,3s)-
21. O,o'-di-p-toluoyl-d-tartaric Acid
22. (s(r*,r*))-2,3-bis((4-methylbenzoyl)oxy)succinic Acid
23. Unii-4480ma5qip
24. D-dtta
25. D-ptta
26. (+)-di-o,o'-p-toluyl-d-tartaric Acid
27. Nsc97592
28. Einecs 251-132-2
29. Nsc 97592
30. Di-p-toluoyl-d-tartaricacid
31. Schembl72682
32. Mls001165767
33. (+)-o,o Inverted Exclamation Mark -di-p-toluoyl-d-tartaric Acid
34. Chembl1490343
35. D-(+)-di-p-toluoyltartaric Acid
36. Dtxsid80885539
37. Hms2855f10
38. D-(+)-di-p-toluoyl-tartaric Acid
39. Act02733
40. Str08702
41. Zinc1632794
42. Di-(4-methyl)benzoyl-d-tartaric Acid
43. Akos000278447
44. Rivastigmine Related Compound A
45. Cs-w020568
46. Di-p-toluoyl-d-tartaric Acid Anhydrous
47. Ks-1018
48. (s,s)-o,o'-di-p-toluoyltartaric Acid
49. D-di-o,o'-p-toluyltartaric Acid
50. Ac-13647
51. Smr000550472
52. Sy004755
53. (+)-o,o'-di-1,4-toluoyl-d-tartaric Acid
54. Am20060204
55. D1417
56. D-(+)-tartaric Acid-o,o'-di-p-toluoyl Ester
57. D-bis(o-4-methylbenzoyl)tartaric Acid
58. O,o'-di-p-toluoyl-d-tartaric Acid Anhydrous
59. (2s,3s)-(+)-di-o-4-toluoyl-d-tartaric Acid
60. 34d687
61. Rivastigmine Related Compound A [usp-rs]
62. (2s,3s)-2,3-bis(4-methylbenzoyloxy)succinic Acid
63. O,o'-di-p-toluoyl-d-tartaric Acid, (+)-
64. Q-201014
65. (2s,3s)-2,3-bis[(4-methybenzoyl)oxy]succinic Acid
66. Q27258721
67. Rivastigmine Related Compound A [usp Impurity]
68. (2s,3s)-2,3-bis-(4-methyl-benzoyloxy)-succinic Acid
69. (+)-o,o'-di-p-toluoyl-d-tartaric Acid, Purum, >=98.0%
70. (2s,3s)-(+)-2,3-bis[(4-methylbenzoyl)oxy]butane-1,4-dioic Acid
71. (+)-o,o'-di-p-toluoyl-d-tartaric Acid, Made From Synthetic Tartaric Acid, 97%
72. Rivastigmine Related Compound A, United States Pharmacopeia (usp) Reference Standard
Molecular Weight | 386.4 g/mol |
---|---|
Molecular Formula | C20H18O8 |
XLogP3 | 3.3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 9 |
Exact Mass | 386.10016753 g/mol |
Monoisotopic Mass | 386.10016753 g/mol |
Topological Polar Surface Area | 127 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 533 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
ABOUT THIS PAGE
26
PharmaCompass offers a list of Di-P-Toluoyl-D-Tartaric Acid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Di-P-Toluoyl-D-Tartaric Acid manufacturer or Di-P-Toluoyl-D-Tartaric Acid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Di-P-Toluoyl-D-Tartaric Acid manufacturer or Di-P-Toluoyl-D-Tartaric Acid supplier.
PharmaCompass also assists you with knowing the Di-P-Toluoyl-D-Tartaric Acid API Price utilized in the formulation of products. Di-P-Toluoyl-D-Tartaric Acid API Price is not always fixed or binding as the Di-P-Toluoyl-D-Tartaric Acid Price is obtained through a variety of data sources. The Di-P-Toluoyl-D-Tartaric Acid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A (+)-dtta manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of (+)-dtta, including repackagers and relabelers. The FDA regulates (+)-dtta manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. (+)-dtta API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of (+)-dtta manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A (+)-dtta supplier is an individual or a company that provides (+)-dtta active pharmaceutical ingredient (API) or (+)-dtta finished formulations upon request. The (+)-dtta suppliers may include (+)-dtta API manufacturers, exporters, distributors and traders.
click here to find a list of (+)-dtta suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A (+)-dtta DMF (Drug Master File) is a document detailing the whole manufacturing process of (+)-dtta active pharmaceutical ingredient (API) in detail. Different forms of (+)-dtta DMFs exist exist since differing nations have different regulations, such as (+)-dtta USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A (+)-dtta DMF submitted to regulatory agencies in the US is known as a USDMF. (+)-dtta USDMF includes data on (+)-dtta's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The (+)-dtta USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of (+)-dtta suppliers with USDMF on PharmaCompass.
(+)-dtta Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of (+)-dtta GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right (+)-dtta GMP manufacturer or (+)-dtta GMP API supplier for your needs.
A (+)-dtta CoA (Certificate of Analysis) is a formal document that attests to (+)-dtta's compliance with (+)-dtta specifications and serves as a tool for batch-level quality control.
(+)-dtta CoA mostly includes findings from lab analyses of a specific batch. For each (+)-dtta CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
(+)-dtta may be tested according to a variety of international standards, such as European Pharmacopoeia ((+)-dtta EP), (+)-dtta JP (Japanese Pharmacopeia) and the US Pharmacopoeia ((+)-dtta USP).